FDA Approves First Gene Therapies for Sickle Cell Disease: A Major Milestone in Healthcare
In a groundbreaking development, the FDA has given its nod to two pioneering treatments, Casgevy and Lyfgenia, marking a historic milestone as the first-ever cell-based gene therap...
Read →